Filters

Drug safety

Showing results (2231-2240 of 3,086) with videos related to

Pageof 309
Sort By:
Drug Safety|June 25, 1998
A risk-benefit assessment of pharmacological treatments for panic disorderJ A Bennett, M Moioffer, S P Stanton, et al.
Drug Safety|June 25, 1998
Drug administration in patients with diabetes mellitus. Safety considerationsR E Gilbert, M E Cooper, H Krum
Drug Safety|June 25, 1998
Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicityC H Wilder-Smith
Drug Safety|February 18, 1998
The TESS database. Use in product safety assessmentT Litovitz
Drug Safety|February 18, 1998
A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesisE A Perez
Drug Safety|February 18, 1998
Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depressionP Mourilhe, P E Stokes
Drug Safety|March 26, 1998
Selecting an antidepressant for use in a patient with epilepsy. Safety considerationsS Curran, K de Pauw
Drug Safety|March 26, 1998
Treating breast cancer during pregnancy. What can be taken safely?M Espié, C Cuvier
Drug Safety|March 26, 1998
Treating recurrent affective disorders during and after pregnancy. What can be taken safely?M Schou
Drug Safety|April 8, 1998
The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspectiveL M Weekes, R O Day
Pageof 309

Showing results (2231-2240 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|June 25, 1998
A risk-benefit assessment of pharmacological treatments for panic disorderJ A Bennett, M Moioffer, S P Stanton, et al.
Drug Safety|June 25, 1998
Drug administration in patients with diabetes mellitus. Safety considerationsR E Gilbert, M E Cooper, H Krum
Drug Safety|June 25, 1998
Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicityC H Wilder-Smith
Drug Safety|February 18, 1998
The TESS database. Use in product safety assessmentT Litovitz
Drug Safety|February 18, 1998
A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesisE A Perez
Drug Safety|February 18, 1998
Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depressionP Mourilhe, P E Stokes
Drug Safety|March 26, 1998
Selecting an antidepressant for use in a patient with epilepsy. Safety considerationsS Curran, K de Pauw
Drug Safety|March 26, 1998
Treating breast cancer during pregnancy. What can be taken safely?M Espié, C Cuvier
Drug Safety|March 26, 1998
Treating recurrent affective disorders during and after pregnancy. What can be taken safely?M Schou
Drug Safety|April 8, 1998
The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspectiveL M Weekes, R O Day
Pageof 309
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us